← Browse by Condition
Medical Condition
vitiligo
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 3, Phase 4
NCT06163326 Phase 3
Recruiting
A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental Vitiligo
Enrollment
400 pts
Location
United States, Austr...
Sponsor
Pfizer
NCT05536856 Phase 4
Recruiting
Topical 5-Fluorouracil Effervescent Powder in the Treatment of Vitiligo
Enrollment
60 pts
Location
Egypt
Sponsor
Al-Azhar University